Non-peptidic, non-prenylic bisubstrate farnesyltransferase inhibitors. Part 3: Structural requirements of the central moiety for farnesyltransferase inhibitory activity
M. Schlitzer et al., Non-peptidic, non-prenylic bisubstrate farnesyltransferase inhibitors. Part 3: Structural requirements of the central moiety for farnesyltransferase inhibitory activity, BIO MED CH, 8(10), 2000, pp. 2399-2406
Recently, we have described non-peptidic, non-prenylic bisubstrate analogue
s as a novel type of farnesyltransferase inhibitor composed of a farnesyl-m
imetic, a linker and an AAX-peptidomimetic substructure. With this study, w
e showed that the amide function connecting the farnesyl-mimetic and the li
nking substructures of our inhibitors is crucial for their activity. We sug
gest that the amide is bound to the essential zinc ion in the farnesyltrans
ferases active center. We identified succinic and glutaric acid, respective
ly, in addition to the initially used beta-alanyl moiety as suitable linkin
g structures. Glycine can also be used in this function provided the distan
ce between the alpha-amide group and the center of the peptidomimetic subst
ructure is enlarged by introduction of an additional methylene unit into th
e peptidomimetic substructure. (C) 2000 Elsevier Science Ltd. All rights re
served.